A Quantitative Reverse Transcription-PCR Assay for Rapid, Automated Analysis of Breast Cancer Sentinel Lymph Nodes
- 30 November 2009
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 11 (6) , 576-582
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Sentinel Node Biopsy: Interpretation and Management of Patients With Immunohistochemistry-Positive Sentinel Nodes and Those With MicrometastasesJournal of Clinical Oncology, 2008
- Nodal Stage Classification for Breast Carcinoma: Improving Interobserver Reproducibility Through Standardized Histologic Criteria and Image-Based TrainingJournal of Clinical Oncology, 2008
- The Prognostic Significance of Micrometastases in Breast Cancer: A SEER Population-Based AnalysisAnnals of Surgical Oncology, 2007
- The prognostic significance of axillary lymph-node micrometastases in breast cancer patientsEuropean Journal of Surgical Oncology, 2005
- Technology for Automated, Rapid, and Quantitative PCR or Reverse Transcription-PCR Clinical TestingClinical Chemistry, 2005
- Improving the reproducibility of diagnosing micrometastases and isolated tumor cellsCancer, 2005
- The clinical significance of axillary lymph node micrometastases in breast cancerEuropean Journal of Surgical Oncology, 2004
- Intraoperative Cytologic Examination of Breast Sentinel Lymph Nodes: Test Utility and Patient ImpactThe Breast Journal, 2004
- Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCRInternational Journal of Cancer, 1998
- Micrometastases and Survival in Stage II Colorectal CancerNew England Journal of Medicine, 1998